Oxytocin Effectiveness in First Trimester Dilatation and Curettage
ConditionMissed Abortion
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorAssuta Ashdod Hospital
About this trial
The aim of this study is to investigate the impact of oxytocin on perioperative blood loss during the D\&C procedure, as well as to assess early and late complications associated with it's use.
Eligibility criteria
Qualifiers
All patients admitted to the OBGYN Assuta Ashdod Hospital for elective surgical termination of pregnancy due to missed miscarriages in the first trimester, with gestational age range of 6.0 to 11.6 weeks.
Disqualifiers
individual intolerance to oxytocin
mullerian anomalies
Fibroid uterus
thrombophilia or coagulation disorders
Trial design
Treatments tested in this trial
- Oxytocin
- Sodium Chloride 0.9% Inj
Treatment groups
160 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov